Back to results
US 10,478,466 B1Granted
Topical vasodilator composition
OwnerPeter Kennedy, Carolyn Shawn Murphyinventors
Life of this patent
Estimating the term…
Abstract
A topical composition comprising from about 0.05% to about 10.0% by weight of Arnica oil, from about 5.0% to about 20.0% by weight of a notoginseng herb comprising dammarane-type ginsenosides, from about 0.05% to about 10% by weight of a compound comprising cyclopentasiloxane, dimethicone crosspolymer, dimethicone/vinyl dimethicone crosspolymer, dimethiconol, and a cosmetically acceptable aqueous carrier.
Claims13
A topical composition comprising:
- (a) from about 0.05% to about 10.0% by weight of Arnica oil;
- (b) from about 5.0% to about 20.0% by weight of a notoginseng herb comprising dammarane-type ginseno sides;
- (c) from about 0.05% to about 10% by weight of a compound comprising cyclopentasiloxane, dimethicone crosspolymer, dimethicone/vinyl dimethicone crosspolymer, and dimethiconol;
- (d) from about 0.05% to about 5.0% by weight cetearyl alcohol;
- (e) from about 0.75% to about 0.85% by weight of a compound formed from diazolidinyl urea (“DU”) and iodopropynyl butylcarbamate (“IPBC”), wherein the ratio of DU to IPBC is substantially 99% to 1% by weight;
- (f) about 0.05% to about 2.5% by weight of dimethyl sulfone;
- (g) about 0.25% weight of phytonadione;
- and
- a cosmetically acceptable aqueous carrier, wherein upon a topical application of the composition to a skin contusion region, such application promotes vasodilatation in the region and dissipation of the contusion, wherein the notoginseng herb comprising dammarane-type ginsenosides is selected from the group consisting of, Panax quinquefolius, Panax vietnamensis, and Panax notoginseng and mixtures thereof.
6 more elements
Dependencies are inferred from the claim text.